Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
14434082 83355 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83355 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
14434082 83355 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83355 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
72791 206489 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 206489 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
72791 206489 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 206489 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
77865 106789 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 106789 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4287 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4287 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
77865 106789 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 106789 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4287 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4287 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
667748 83358 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83358 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
667748 83358 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83358 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1474 153853 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153853 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
1474 153853 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153853 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
74265 206596 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 206596 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83359 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83359 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
70848 204935 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204935 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 198031 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 198031 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
74265 206596 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 206596 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83359 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83359 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
2733927 83361 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83361 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
70848 204935 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204935 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 198031 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 198031 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
2733927 83361 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83361 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
15783796 83364 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83364 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 106704 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106704 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83362 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83362 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15783796 83364 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83364 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 106704 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106704 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83362 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83362 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15664 83360 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83360 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
15664 83360 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83360 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
77524 55582 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55582 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
77524 55582 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55582 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
10391001 136661 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 136661 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11541506 76148 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76148 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105860 136666 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374978 136666 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105782 82279 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217965 82279 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
16112836 92920 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 92920 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439843 91095 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL240462 91095 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
16105780 84164 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222112 84164 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
44598057 195384 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL567419 195384 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11533398 75618 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 75618 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
44457090 97200 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL271128 97200 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950828 97159 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
CHEMBL270971 97159 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
11950828 97159 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
CHEMBL270971 97159 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
44457090 97200 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
CHEMBL271128 97200 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
44457009 158450 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
CHEMBL409648 158450 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
16105857 165638 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426551 165638 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10480554 149670 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395211 149670 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439881 93354 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247563 93354 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10004785 93398 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247762 93398 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439890 93469 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
CHEMBL248171 93469 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
44439886 93430 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247964 93430 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439895 149921 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395423 149921 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065425 195542 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
CHEMBL568296 195542 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
16105885 82347 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217984 82347 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
44598821 196251 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL573216 196251 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
44598059 195327 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL566974 195327 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
44598769 195413 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL567620 195413 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
16105854 83484 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220650 83484 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065428 196171 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
CHEMBL572537 196171 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
16105774 83893 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL221601 83893 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
3384970 160722 8 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 160722 8 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
16105862 82962 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219432 82962 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
44439837 147432 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL393411 147432 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44457089 97199 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
CHEMBL271127 97199 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
11950826 158631 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL409849 158631 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456993 97325 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL271801 97325 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
44456993 97325 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL271801 97325 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44598060 195580 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL568503 195580 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
44457046 166770 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL429436 166770 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44457046 166770 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL429436 166770 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105772 82946 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219380 82946 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
16105819 84055 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL222020 84055 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
16112836 92920 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 92920 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
45483901 195383 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567417 195383 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16064872 195585 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
CHEMBL568523 195585 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
44598124 196951 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
CHEMBL579072 196951 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
45483880 195541 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL568294 195541 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16105859 83898 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221639 83898 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
16105864 83932 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221842 83932 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
16105855 82716 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218209 82716 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
11584004 140154 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140154 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
45483913 195244 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
CHEMBL566324 195244 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
44598121 195414 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567627 195414 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
16105777 136423 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374414 136423 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
16105776 136399 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374274 136399 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
9911916 91233 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240848 91233 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10433657 93431 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247965 93431 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11842667 160487 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
CHEMBL411651 160487 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
44456948 159558 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL410885 159558 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456948 159558 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL410885 159558 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105887 83915 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221712 83915 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
16105865 168764 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL441870 168764 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
16065567 197138 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL583621 197138 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
10479253 91094 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
CHEMBL240461 91094 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
44439883 93397 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247761 93397 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10412437 150785 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396102 150785 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11951000 97360 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
CHEMBL272022 97360 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
44457093 97316 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL271768 97316 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11951000 97360 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
CHEMBL272022 97360 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
44457105 158056 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
CHEMBL409224 158056 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
44457105 158056 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
CHEMBL409224 158056 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
16105775 82961 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL219431 82961 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
16105868 137500 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376517 137500 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16105867 137328 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376071 137328 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
16105863 83900 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221650 83900 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
10003657 152286 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL397395 152286 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11685733 139659 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 139659 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105817 136435 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374527 136435 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
44598058 196445 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
CHEMBL574655 196445 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
16105781 82733 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218298 82733 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
11526626 75176 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75176 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105779 136664 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374964 136664 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
16105778 82171 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217909 82171 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
16105858 83928 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221790 83928 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
44598062 195584 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL568522 195584 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
10255258 149923 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395424 149923 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16112836 92920 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 92920 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10409369 168927 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL443315 168927 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
44598820 197093 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
CHEMBL583212 197093 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
11965686 197167 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
CHEMBL583843 197167 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
11539239 77757 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 77757 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
11519336 77508 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77508 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105783 82784 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218554 82784 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
16105773 83975 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221978 83975 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105784 83889 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221586 83889 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065704 197185 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL584087 197185 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
16105861 82732 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218297 82732 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105787 83485 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220651 83485 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
10343818 150814 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396124 150814 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439838 90918 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240249 90918 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439887 93468 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL248169 93468 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439909 166957 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL430012 166957 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16105786 141163 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385654 141163 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
16105856 83486 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220652 83486 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
44598819 195307 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL566759 195307 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950827 97158 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
CHEMBL270969 97158 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
10412573 93355 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247564 93355 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439885 93429 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247963 93429 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065569 195282 20 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL566543 195282 20 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
11273324 95449 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL259243 95449 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11273324 95449 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL259243 95449 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
16105866 82785 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218555 82785 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
16105771 84121 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222062 84121 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105815 82751 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218369 82751 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
44598061 195352 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL567202 195352 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
15664 83360 93 None -2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
CHEMBL2205807 83360 93 None -2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
486830 3927 0 None -10 5 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
768 3927 0 None -10 5 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 808 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 808 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
812 808 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16221874
815 3926 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
815 3926 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
816 3925 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
11688990 4068 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
813 4068 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
CHEMBL1883966 4068 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
155557362 174061 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
CHEMBL4558185 174061 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
132072454 179134 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4744046 179134 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
10367938 82752 0 None - 1 Human 9.8 pKi = 9.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218374 82752 0 None - 1 Human 9.8 pKi = 9.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391001 136661 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 136661 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11754900 83934 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221865 83934 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
10006907 141270 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141270 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
10006907 141270 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141270 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
9984180 136013 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373739 136013 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
16105811 137131 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL375854 137131 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
16105788 82753 6 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218375 82753 6 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105880 83936 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221867 83936 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
16105822 137618 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL376910 137618 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
16105890 141402 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387161 141402 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11519336 77508 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77508 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105807 83544 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL220703 83544 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
16105813 83815 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221078 83815 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
16105831 82987 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219589 82987 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11502217 75667 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205692 75667 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11526626 75176 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75176 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105760 137329 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376076 137329 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105805 83970 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221961 83970 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105799 165582 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426207 165582 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11774008 84162 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222110 84162 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105809 83897 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221638 83897 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
16105889 83543 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220701 83543 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
9982672 82399 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
CHEMBL218037 82399 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
16105802 83637 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220753 83637 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105895 141374 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
CHEMBL386987 141374 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
11563243 168124 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL436753 168124 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
11270007 84163 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222111 84163 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105888 135838 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373504 135838 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
11541073 75622 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
CHEMBL205457 75622 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
11539239 77757 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 77757 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
792361 75823 7 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205808 75823 7 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11584004 140154 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140154 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
16105891 83821 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221130 83821 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
44419035 83851 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221345 83851 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11384528 141088 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL385287 141088 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105832 82934 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL219327 82934 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
44419032 84120 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222058 84120 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105840 83927 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221789 83927 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10254576 83942 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221904 83942 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
16105824 83840 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221251 83840 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
16105892 141063 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL385108 141063 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
11452569 82774 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218503 82774 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
3384970 160722 8 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 160722 8 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
44419031 137164 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375880 137164 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391077 136846 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375315 136846 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105877 82398 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218036 82398 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
16105844 82345 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL217979 82345 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
16105830 82971 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219487 82971 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11235229 82986 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL219588 82986 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
11541506 76148 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76148 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105893 82720 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218218 82720 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105803 83974 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221977 83974 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11706579 139194 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
CHEMBL379834 139194 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
11533398 75618 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 75618 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
16105876 136667 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374979 136667 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
16105826 82749 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218366 82749 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105820 141089 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385288 141089 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105821 82745 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218350 82745 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
1099153 82715 10 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218207 82715 10 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105882 141451 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387451 141451 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11685733 139659 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 139659 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105804 82963 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL219433 82963 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
11329260 83809 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221021 83809 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11530171 75602 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205304 75602 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11681610 140042 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL381354 140042 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z